BioLife Solutions, Inc.
BLFS
$21.90
$0.914.34%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 82.25M | 79.54M | 72.54M | 73.45M | 75.86M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 82.25M | 79.54M | 72.54M | 73.45M | 75.86M |
| Cost of Revenue | 28.58M | 25.21M | 22.51M | 27.29M | 29.92M |
| Gross Profit | 53.67M | 54.33M | 50.03M | 46.16M | 45.93M |
| SG&A Expenses | 50.15M | 50.03M | 50.83M | 53.80M | 55.97M |
| Depreciation & Amortization | 2.74M | 2.12M | 2.52M | 3.02M | 3.52M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 89.38M | 85.49M | 85.67M | 95.33M | 101.49M |
| Operating Income | -7.13M | -5.95M | -13.13M | -21.88M | -25.63M |
| Income Before Tax | -11.43M | -1.61M | -15.56M | -13.93M | -18.47M |
| Income Tax Expenses | -38.00K | -140.00K | 3.00K | 5.00K | -24.00K |
| Earnings from Continuing Operations | -11.39 | -1.47 | -15.57 | -13.94 | -18.45 |
| Earnings from Discontinued Operations | -8.80M | -46.14M | -59.46M | -50.57M | -49.56M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -20.18M | -47.60M | -75.03M | -64.51M | -68.00M |
| EBIT | -7.13M | -5.95M | -13.13M | -21.88M | -25.63M |
| EBITDA | 1.20M | 3.40M | -2.93M | -10.99M | -13.84M |
| EPS Basic | -0.45 | -1.05 | -1.68 | -1.46 | -1.56 |
| Normalized Basic EPS | -0.10 | -0.08 | -0.19 | -0.31 | -0.37 |
| EPS Diluted | -0.46 | -1.05 | -1.68 | -1.46 | -1.56 |
| Normalized Diluted EPS | -0.10 | -0.08 | -0.19 | -0.31 | -0.37 |
| Average Basic Shares Outstanding | 184.26M | 182.43M | 179.83M | 177.27M | 174.86M |
| Average Diluted Shares Outstanding | 185.64M | 182.43M | 179.83M | 177.27M | 174.86M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
